Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 194,749 | 123,803 | 2,108 | 0 | 0 |
| Cost of Goods | 3,316 | 1,986 | 48 | N/A | N/A |
| Gross Profit | 191,433 | 121,817 | 2,060 | N/A | N/A |
| Operating Expenses | 479,439 | 365,975 | 283,391 | 182,742 | 119,245 |
| Operating Income | -287,690 | -243,172 | -281,283 | -182,742 | -119,245 |
| Interest Expense | 15,467 | 9,809 | 894 | 346 | 0 |
| Other Income | 543 | 5,428 | 15,415 | 8,895 | 2,221 |
| Pre-tax Income | -302,614 | -247,553 | -266,762 | -174,193 | -117,024 |
| Income Tax | 477 | N/A | 4 | N/A | N/A |
| Net Income Continuous | -303,091 | -247,553 | -266,766 | -174,193 | -117,024 |
| Net Income | $-303,091 | $-247,553 | $-266,766 | $-174,193 | $-117,024 |
| EPS Basic Total Ops | -4.81 | -4.04 | -4.57 | -3.41 | -2.76 |
| EPS Basic Continuous Ops | -4.81 | -4.04 | -4.57 | -3.41 | -2.77 |
| EPS Diluted Total Ops | -4.81 | -4.04 | -4.57 | -3.41 | -2.76 |
| EPS Diluted Continuous Ops | -4.81 | -4.04 | -4.57 | -3.41 | -2.77 |
| EPS Diluted Before Non-Recurring Items | -4.81 | -4.04 | -4.71 | -3.41 | -2.76 |
| EBITDA(a) | $-278,869 | $-232,230 | $-273,408 | $-178,796 | $-116,883 |